MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • MDS Virtual Congress 2021

    Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort

    A. Neji, A. Nasri, I. Sghaier, S. Mrabet, M. Bendjebara, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To investigate survival and its determinants in a Tunisian cohort of Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative tauopathy characterized by faster…
  • MDS Virtual Congress 2021

    Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort – the OxQUIP study.

    M. Pereira, C. Antoniades (Oxford, United Kingdom)

    Objective: We aimed to determine longitudinal changes in motor and cognitive features of Progressive Supranuclear Palsy using multiple closely spaced follow-up timepoints over a period…
  • MDS Virtual Congress 2021

    Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders

    M. Peres, G. Leroy, A. Gerhard, M. Hu, J. Klein, P. Leigh, A. Church, D. Burn, H. Morris, J. Rowe, T. Rittman (Cambridge, United Kingdom)

    Objective: Our primary goal was to implement an automated measure of the midbrain to pons ratio (MPR) using an artificial intelligence method. Our second objective…
  • MDS Virtual Congress 2021

    A retrospective review of clinical features of Progressive Supranuclear Palsy (PSP) in a movement disorders clinic

    G. Shepherd, T. Wongwarawipat, A. Chatterjee (Reading, United Kingdom)

    Objective: Understanding the common clinical features of PSP. Background: PSP is a relatively rare progressive neurodegenerative disease, which can often be difficult to distinguish from…
  • MDS Virtual Congress 2021

    Backward Fall Protection Garment for patients of PSP and other Parkinsonian Syndromes.

    H. Singh, D. Singhal, N. Sawal, A. Beri, S. Kumar, G. Hundal, A. Chawla (Chandigarh, India)

    Objective: To create a sensor controlled wearable system with an inflatable collar that offers protection against head, spine and shoulder girdle injuries in case of…
  • MDS Virtual Congress 2021

    Neuroimaging associations to gait impairments in progressive supranuclear palsy

    I. Sintini, K. Kaufman, S. Loushin, H. Botha, P. Martin, M. Senjem, R. Reid, C. Schwarz, C. Jack, V. Lowe, K. Josephs, J. Whitwell, F. Ali (Rochester, USA)

    Objective: The aim of this study was to determine how multimodal imaging biomarkers were related to abnormalities in three-dimensional motion-based gait and balance measurements in…
  • MDS Virtual Congress 2021

    The loss of skeletal muscle mass in progressive supranuclear palsy

    Y. Takamatsu, I. Aiba (Sapporo, Japan)

    Objective: To investigate body composition parameters, focusing on skeletal muscle mass, in patients with progressive supranuclear palsy (PSP) and compared them with those of healthy…
  • MDS Virtual Congress 2021

    A retrospective review of clinical and MRI/CT radiological correlation in progressive supranuclear palsy (PSP)

    T. Wongwarawipat, G. Shepherd, A. Chatterjee (Reading, United Kingdom)

    Objective: To investigate the clinical and MRI/CT radiological correlation to improve the diagnosis and management of PSP Background: PSP is a rare progressive neurodegenerative disease…
  • MDS Virtual Congress 2021

    New presenilin-1 missense variant (p.Pro88Arg) characterized by initial progressive supranuclear palsy like phenotype.

    Q. Thomas, S. Nambot, C. Thauvin-Robinet, C. Philippe, Y. Bejot, G. Dupont (Dijon, France)

    Objective: To report a new presenilin-1 (PSEN 1) missense variant (p.Pro88Arg) characterized by initial Progressive Supranuclear Palsy (PSP) like phenotype. Background: Pathogenic variants in the PSEN1gene…
  • MDS Virtual Congress 2021

    Quantitative downgaze palsy predicts the survival duration in patients with progressive supranuclear palsy

    T. Xie, C. Yuen, W. Kang, M. Padmanaban, T. Han, J. Nichols (Chicago, USA)

    Objective: To study whether quantitative downgaze palsy could predict the survival duration in patients with progressive supranuclear palsy (PSP). Background: No clinical feature has been…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 38
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley